Specialty-chemicals operator in Materials sector. ₹5,101 Cr market cap, ₹4,215.7 share. Revenue up 75% in nine months (Sep 2025 to Jun 2026), profit up steeper.
Generated analysis · source review pending
Generated analysis · source review pending
Beta is measured against NIFTY 50 over three years of weekly returns — 1 moves with the index, above 1 amplifies it, below 1 damps it.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
No scheme among the 32 fund houses on record reported a position in Yasho Industries Limited. Portfolios are published monthly by each AMC; coverage is still partial.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Gujarat Fluorochemicals LimitedFLUOROCHEMFLUOROCHEM | ₹47,713 Cr | ₹49,912 Cr | ₹5,303 Cr | ₹1,375 Cr | 25.8% | ₹615 Cr | 11.5% | 11.1% | 7.6% | 401 |
| Navin Fluorine International LimitedNAVINFLUORNAVINFLUOR | ₹41,740 Cr | ₹42,967 Cr | ₹3,634 Cr | ₹1,232 Cr | 32.6% | ₹790 Cr | 20% | 21.6% | 20.1% | 61 |
| Aether Industries LimitedAETHERAETHER | ₹22,161 Cr | ₹22,603 Cr | ₹1,224 Cr | ₹384 Cr | 31.3% | ₹235 Cr | 19.8% | 13.2% | 9.4% | 330 |
| Atul LimitedATULATUL | ₹17,231 Cr | ₹17,411 Cr | ₹6,643 Cr | ₹1,189 Cr | 16.4% | ₹704 Cr | 11% | 14.1% | 11.5% | 70 |
| Aarti Industries LimitedAARTIINDAARTIIND | ₹16,869 Cr | ₹21,790 Cr | ₹9,012 Cr | ₹1,337 Cr | 14.1% | ₹531 Cr | 5.1% | 8.8% | 7.3% | 54 |
| Fine Organic Industries LimitedFINEORGFINEORG | ₹15,752 Cr | ₹15,797 Cr | ₹2,472 Cr | ₹535 Cr | 20.4% | ₹438 Cr | 17.6% | 21.6% | 16.8% | 113 |
| Basf India LimitedBASFBASF | ₹14,796 Cr | ₹14,796 Cr | ₹16,177 Cr | ₹952 Cr | 4.4% | ₹643 Cr | 2.8% | 14% | 11.1% | 40 |
| Privi Speciality Chemicals LimitedPRIVISCLPRIVISCL | ₹13,970 Cr | ₹14,980 Cr | ₹2,671 Cr | ₹666 Cr | 25.2% | ₹342 Cr | 12.4% | 27.7% | 25.2% | 158 |
| Sudeep Pharma LimitedSUDEEPPHRMSUDEEPPHRM | ₹13,546 Cr | ₹13,694 Cr | ₹676 Cr | ₹233 Cr | 34.6% | ₹133 Cr | 27.1% | 31.1% | 25.2% | 366 |
| Anupam Rasayan India LimitedANURASANURAS | ₹13,243 Cr | ₹15,058 Cr | ₹2,535 Cr | ₹563 Cr | 22.2% | ₹175 Cr | 9.4% | 9.1% | 5.5% | 377 |
| Vinati Organics LimitedVINATIORGAVINATIORGA | ₹12,528 Cr | ₹12,528 Cr | ₹2,381 Cr | ₹665 Cr | 29.4% | ₹448 Cr | 19.9% | 18.8% | 14.9% | 152 |
| Elantas Beck India LimitedELANTASELANTAS | ₹10,644 Cr | ₹10,644 Cr | ₹778 Cr | ₹147 Cr | 20.3% | ₹136 Cr | 17.4% | 20.6% | 15.8% | 70 |
Consolidated figures
| Ratio | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Margins | ||||
| Gross margin % | 38.2% | 36% | 41.7% | 39.6% |
| EBITDA margin % | 17.1% | 16.8% | 16.4% | 17.3% |
| EBIT margin % | 14.2% | 14.2% | 8.9% | 10.7% |
| PAT margin % | 10.1% | 9.8% | 0.9% | 3% |
| Working capital | ||||
| Receivable days | 56 | 74 | 73 | 80 |
| Inventory days | 147 | 130 | 247 | 186 |
| Payable days | 45 | 46 | 61 | 65 |
| NWC days | 158 | 157 | 259 | 201 |
| Leverage | ||||
| Current ratio | 1.43 | 1.08 | 1.39 | 1.37 |
| Debt to EBITDA | 2.75 | 5.5 | 5.1 | 3.78 |
| Debt to equity | 1.33 | 1.86 | 1.33 | 1.22 |
| Interest coverage | 6.8 | 6.2 | 1.2 | 1.6 |
| Asset turnover | 1.03 | 0.6 | 0.61 | 0.72 |
| Return ratios | ||||
| Return on assets % | 10.4% | 5.8% | 0.6% | 2.2% |
| Return on capital employed % | 24.6% | 16% | 9.2% | 11.5% |
| Return on equity % | 28.5% | 19.7% | 1.5% | 5.7% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
| Holder (%) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71.54% | 72.33% | 71.92% | 71.92% | 71.92% | 71.92% | 67.99% | 67.99% | 67.99% | 67.99% | 67.91% | 67.94% | |
| 0.13% | 0.13% | 1.05% | 0.97% | 0.99% | 1.41% | 7.24% | 6.99% | 6.9% | 7% | 5.71% | 5.74% | |
| 0% | 0% | 0% | 0% | 0.09% | 0.28% | 0.51% | 0.94% | 0.96% | 1.05% | 1.97% | 2.21% | |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 28.33% | 27.54% | 27.03% | 27.11% | 27% | 26.39% | 24.26% | 24.08% | 24.15% | 23.96% | 24.41% | 24.11% | |
| No. of shareholders | — | — | — | — | — | — | — | — | 26,407 | 25,163 | 23,730 | 22,694 |
Promoter holding down 3.6 percentage points since Sep 2023.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 26 Feb 2024 | GRAVITON RESEARCH CAPITAL LLP | Bulk | NSE | Buy | 57,351 | ₹2,271.72 | ₹13.03 Cr |
| 26 Feb 2024 | GRAVITON RESEARCH CAPITAL LLP | Bulk | NSE | Sell | 57,350 | ₹2,274.52 | ₹13.04 Cr |
| 9 Jan 2024 | NISHIGANDHA POLYMERS P.LTD | Block | NSE | Sell | 95,000 | ₹1,625.00 | ₹15.44 Cr |
| 9 Jan 2024 | NEUBERGER BERMAN BD LLC | Block | NSE | Buy | 95,000 | ₹1,625.00 | ₹15.44 Cr |
| 9 Jan 2024 | NISHIGANDHA POLYMERS P.LTD | Bulk | NSE | Sell | 95,000 | ₹1,625.00 | ₹15.44 Cr |
| 27 Dec 2022 | JIGNESH AMRUTLAL THOBHANI | Bulk | BSE | Sell | 61,500 | ₹1,613.35 | ₹9.92 Cr |
| 5 Oct 2021 | VINEY CORPORATION PRIVATE LIMITED | Bulk | BSE | Sell | 77,512 | ₹1,039.80 | ₹8.06 Cr |
| 29 Sept 2021 | JIGNESH AMRUTLAL THOBHANI | Bulk | BSE | Sell | 70,000 | ₹694.64 | ₹4.86 Cr |
| 13 Sept 2021 | ARC FINANCE LIMITED | Bulk | BSE | Sell | 86,651 | ₹736.86 | ₹6.38 Cr |
| 9 Aug 2021 | EMRALD COMMERCIAL LIMITED | Bulk | BSE | Sell | 63,180 | ₹672.59 | ₹4.25 Cr |
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
Documents link to external sources (exchange filings, company investor pages).
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)-Credit Rating
Closure of Trading Window
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Compliances-Reg.24(A)-Annual Secretarial Compliance
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
| Date | Category | Subject | Filing |
|---|---|---|---|
| 13 Jul 2026, 6:05 pm | Company Update Newspaper Publication | Announcement under Regulation 30 (LODR)-Newspaper Publication | |
| 9 Jul 2026, 12:47 pm | Company Update Credit Rating | Announcement under Regulation 30 (LODR)-Credit Rating |
| 23 Jun 2026, 9:59 am | Insider Trading / SAST Closure of Trading Window | Closure of Trading Window |
| 16 Jun 2026, 12:23 pm | Company Update Analyst / Investor Meet | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| 26 May 2026, 5:15 pm | Company Update Reg.24(A)-Annual Secretarial Compliance | Compliances-Reg.24(A)-Annual Secretarial Compliance |
| 22 May 2026, 3:34 pm | Company Update Earnings Call Transcript | Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| 20 May 2026, 11:15 am | Company Update Analyst / Investor Meet | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| 19 May 2026, 5:36 pm | Company Update Analyst / Investor Meet | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
Consolidated figures · ₹ crore
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 672 | 594 | 669 | 830 | |
| COGS | 415 | 380 | 390 | 502 |
| Gross profit | 256 | 213 | 278 | 329 |
| 141 | 114 | 169 | 185 | |
| 115 | 100 | 110 | 143 | |
| OPM % | 17.1% | 16.8% | 16.4% | 17.3% |
| Depreciation | 20 | 16 | 50 | 55 |
| Interest | 16 | 15 | 59 | 56 |
| 11 | 7 | 9 | 1 | |
| Profit before tax | 91 | 77 | 9 | 34 |
| Tax | 23 | 19 | 3 | 9 |
| Tax % | 25.1% | 24.5% | 32.3% | 25.6% |
| 68 | 58 | 6 | 25 | |
| PAT margin % | 10.1% | 9.8% | 0.9% | 3% |
| EPS (₹) | 59.5 | 50.8 | 5.3 | 21 |
| EPS adjusted (₹) | 59.5 | 50.8 | 5.1 | 21 |
| 0.8% | 1% | 9.4% | 2.4% | |
| Annual report | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | Annual report for Mar 2026 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 11 | 11 | 11 | 11 | 12 | 12 |
| Reserves | 68 | — | 227 | 283 | 408 | 432 |
| 161 | — | 316 | 548 | 559 | 541 | |
| 66 | — | 96 | 150 | 116 | 170 | |
| Total equity & liabilities | 305 | — | 650 | 993 | 1,094 | 1,155 |
| 120 | 161 | 177 | 203 | 624 | 619 | |
| CWIP | 1 | — | 123 | 461 | 1 | 10 |
| Investments | 0 | — | 0 | 0 | 0 | 15 |
| 185 | — | 350 | 329 | 469 | 511 | |
| Total assets | 305 | — | 650 | 993 | 1,094 | 1,155 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 35 | 16 | 13 | 122 | -42 | 151 | |
| -14 | -59 | -132 | -336 | -9 | -73 | |
| -21 | 43 | 122 | 214 | 59 | -81 | |
| Net cash flow | 0 | -0 | 3 | -0 | 8 | -2 |
| Free cash flow | — | — | -136 | -212 | -45 | 85 |
| CFO / Operating profit % | — | — | 10.9% | 121.9% | -38.3% | 105.7% |